{
    "id": "ngn_trend_B300_165_1771350279639",
    "version": 1,
    "questionType": "trend",
    "cjjmStep": "analyzeCues",
    "difficulty": 4,
    "stem": "A 45-year-old client was admitted to the medical-surgical unit for management of a suspected pheochromocytoma. The client is being prepared for a future adrenalectomy. The nurse is reviewing the client's electronic health record after an alpha-adrenergic blocking agent (phenoxybenzamine) was initiated on the evening of Day 2.",
    "prompt": "The nurse reviews the client's trended data. Which **3** findings are most significant for the nurse to analyze at this time?",
    "trend": {
        "header": "Client Progress Note",
        "introduction": "Client is a 45-year-old with a hypertensive crisis. Phenoxybenzamine 10 mg PO BID was initiated on Day 2 at 1800.",
        "columns": [
            {
                "id": "col_0",
                "header": "Assessment Finding"
            },
            {
                "id": "col_1",
                "header": "Day 1 (Admission)"
            },
            {
                "id": "col_2",
                "header": "Day 2 (1000)"
            },
            {
                "id": "col_3",
                "header": "Day 3 (1000)"
            }
        ],
        "rows": [
            {
                "id": "row_0",
                "cells": [
                    {
                        "id": "opt_0_0",
                        "text": "Blood Pressure (Lying)"
                    },
                    {
                        "id": "opt_0_1",
                        "text": "210/118 mmHg"
                    },
                    {
                        "id": "opt_0_2",
                        "text": "188/104 mmHg"
                    },
                    {
                        "id": "opt_0_3",
                        "text": "142/88 mmHg"
                    }
                ]
            },
            {
                "id": "row_1",
                "cells": [
                    {
                        "id": "opt_1_0",
                        "text": "Blood Pressure (Standing)"
                    },
                    {
                        "id": "opt_1_1",
                        "text": "206/115 mmHg"
                    },
                    {
                        "id": "opt_1_2",
                        "text": "184/100 mmHg"
                    },
                    {
                        "id": "opt_1_3",
                        "text": "110/70 mmHg"
                    }
                ]
            },
            {
                "id": "row_2",
                "cells": [
                    {
                        "id": "opt_2_0",
                        "text": "Heart Rate"
                    },
                    {
                        "id": "opt_2_1",
                        "text": "115/min"
                    },
                    {
                        "id": "opt_2_2",
                        "text": "108/min"
                    },
                    {
                        "id": "opt_2_3",
                        "text": "112/min"
                    }
                ]
            },
            {
                "id": "row_3",
                "cells": [
                    {
                        "id": "opt_3_0",
                        "text": "24-hr Urine Metanephrines"
                    },
                    {
                        "id": "opt_3_1",
                        "text": "Pending"
                    },
                    {
                        "id": "opt_3_2",
                        "text": "Resulted: 3.8 mcg/24h (Ref: <1.0 mcg/24h)"
                    },
                    {
                        "id": "opt_3_3",
                        "text": "Not repeated"
                    }
                ]
            },
            {
                "id": "row_4",
                "cells": [
                    {
                        "id": "opt_4_0",
                        "text": "Client Report: Headache (0-10)"
                    },
                    {
                        "id": "opt_4_1",
                        "text": "9"
                    },
                    {
                        "id": "opt_4_2",
                        "text": "6"
                    },
                    {
                        "id": "opt_4_3",
                        "text": "2"
                    }
                ]
            },
            {
                "id": "row_5",
                "cells": [
                    {
                        "id": "opt_5_0",
                        "text": "Client Report: Dizziness on standing"
                    },
                    {
                        "id": "opt_5_1",
                        "text": "No"
                    },
                    {
                        "id": "opt_5_2",
                        "text": "No"
                    },
                    {
                        "id": "opt_5_3",
                        "text": "Yes"
                    }
                ]
            }
        ]
    },
    "answer": [
        "opt_1_3",
        "opt_3_2",
        "opt_5_3"
    ],
    "answerBreakdown": {
        "correct": [
            {
                "optionId": "opt_1_3",
                "rationale": "This finding is highly significant because the dramatic drop in blood pressure from lying (142/88 mmHg) to standing (110/70 mmHg) indicates orthostatic hypotension. This is an expected therapeutic effect of the alpha-blocker phenoxybenzamine, demonstrating that the medication is effectively blocking catecholamine-induced vasoconstriction. It confirms the treatment is working but also identifies a critical safety risk (falls) that the nurse must manage."
            },
            {
                "optionId": "opt_3_2",
                "rationale": "This finding is significant as it provides the definitive biochemical diagnosis of pheochromocytoma. The markedly elevated urine metanephrines confirm that the client's hypertensive crisis is caused by excessive catecholamine secretion from a tumor. This lab result is the cornerstone of the diagnosis and justifies the entire preoperative management plan, including the use of alpha-blockade."
            },
            {
                "optionId": "opt_5_3",
                "rationale": "This finding is significant because the client's subjective report of dizziness directly correlates with the objective measurement of orthostatic hypotension (opt_1_3). This symptom confirms that the client is experiencing the effects of the blood pressure drop, which requires immediate nursing intervention, including client education on changing positions slowly and implementing fall precautions."
            }
        ],
        "incorrect": [
            {
                "optionId": "opt_0_1",
                "rationale": "The initial severe hypertension is the reason for admission but is not a key finding to analyze in response to the treatment initiated on Day 2."
            },
            {
                "optionId": "opt_0_2",
                "rationale": "This blood pressure reading was taken before the alpha-blocker was started. While it shows a slight improvement, it is part of the baseline data prior to the key intervention."
            },
            {
                "optionId": "opt_0_3",
                "rationale": "While the decrease in lying blood pressure to 142/88 mmHg shows a positive response to treatment, the orthostatic change (the difference between lying and standing BP) is a more specific and significant indicator of the alpha-blockade's effect and associated risks."
            },
            {
                "optionId": "opt_1_1",
                "rationale": "This standing blood pressure on admission is part of the initial presentation of severe hypertension and does not reflect a response to the specific therapy being evaluated."
            },
            {
                "optionId": "opt_1_2",
                "rationale": "This standing blood pressure was taken before the initiation of phenoxybenzamine, so it does not help the nurse analyze the client's response to that medication."
            },
            {
                "optionId": "opt_2_1",
                "rationale": "The initial tachycardia is an expected finding in a catecholamine crisis associated with pheochromocytoma. It's a baseline cue, not a response to the treatment initiated on Day 2."
            },
            {
                "optionId": "opt_2_2",
                "rationale": "This heart rate prior to the alpha-blocker initiation is part of the baseline trend. It is still elevated, as expected."
            },
            {
                "optionId": "opt_2_3",
                "rationale": "A stable or slightly increased heart rate is expected after starting an alpha-blocker due to reflex tachycardia as blood pressure decreases. While a relevant finding, it is less significant for analysis than the development of orthostatic hypotension and its associated symptoms, which is the primary therapeutic goal and safety concern."
            },
            {
                "optionId": "opt_3_1",
                "rationale": "A pending lab result provides no data for the nurse to analyze."
            },
            {
                "optionId": "opt_3_3",
                "rationale": "This indicates the lab was not repeated, which is appropriate as one positive test is sufficient for diagnosis. It does not provide new information for analysis."
            },
            {
                "optionId": "opt_4_1",
                "rationale": "The severe headache on admission is a classic symptom of pheochromocytoma, but it is a baseline finding, not a measure of treatment response to the alpha-blocker."
            },
            {
                "optionId": "opt_4_2",
                "rationale": "The decrease in headache severity before the alpha-blocker was started is a positive sign, likely due to initial IV antihypertensives, but it doesn't reflect the effect of the specific medication being analyzed."
            },
            {
                "optionId": "opt_4_3",
                "rationale": "The significant improvement in the client's headache is an expected and positive outcome of blood pressure control. However, analyzing the hemodynamic changes (orthostasis) and the reason for treatment (metanephrines) is more critical for managing this client's specific condition and ensuring safety."
            },
            {
                "optionId": "opt_5_1",
                "rationale": "The absence of dizziness on admission is a baseline finding."
            },
            {
                "optionId": "opt_5_2",
                "rationale": "The absence of dizziness before starting the alpha-blocker is an expected baseline finding."
            }
        ]
    }
}